OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
CPMD
Cannapharmarx Inc.
Common Stock
0.0044
0.00
0.00%
0.002 / 0.004 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 06/10/2025
Delayed (15 Min) Trade Data: 12:00am 06/05/2025
Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.0.00
N/A
0
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For CPMDFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 06/05/2025 | 09:41:52 | 0.0044 | 0.00 | 70,000 |
| 06/05/2025 | 09:30:21 | 0.0038 | 0.00 | 23,088 |
| 06/04/2025 | 15:40:27 | 0.0038 | 0.00 | 5,000 |
| 06/04/2025 | 15:39:44 | 0.0038 | 0.00 | 5,000 |
| 06/04/2025 | 15:39:08 | 0.0038 | 0.00 | 5,000 |
News
CannaPharmaRx Announces CannaSyn Drug Discovery PlatformMarketwired | 11/30/2015
CannaPharmaRx to Exhibit and Present at The MoneyShow in San Francisco, CaliforniaMarketwired | 07/15/2015
CannaPharmaRx Closes Merger of Colorado SubsidiaryMarketwired | 07/01/2015
Filings and Disclosure
Company Description
CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to
advance cannabinoid research and discovery using proprietary formulation and drug
delivery technology currently in development. Cannabinoids are a class of chemicals
that, once ingested, are active in humans and animals through the "endocannabinoid
system" -- one of the most widely expressed system of receptors in the human body.
CannaPharmaRx is currently focused on targeting disease states where its delivery
systems can have optimal impact with therapeutic differentiation among alternative
cannabinoid therapies, including: neurological disorders, oncology, infectious disease,
pain management, inflammatory disease, gastrointestinal disorders and ophthalmology.
Videos
This company has not added any videos
Pink Current Information
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
50.70
Change
-0.10 (-0.20%)
Bid
50.00
Ask
50.75
Volume
2026
Time
15:44
